proglumide has been researched along with Obesity, Morbid in 1 studies
Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirsch, DP | 1 |
| Mathus-Vliegen, EM | 1 |
| Holloway, RH | 1 |
| Fakhry, N | 1 |
| D'Amato, M | 1 |
| Boeckxstaens, GE | 1 |
1 trial available for proglumide and Obesity, Morbid
| Article | Year |
|---|---|
Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.
Topics: Adult; Esophagogastric Junction; Hormone Antagonists; Humans; Manometry; Middle Aged; Obesity, Morbi | 2002 |